Historical perspective on the progress of chemotherapy-induced nausea and vomiting treatment in oncology nursing forum

Oncology Nursing Forum

Volumn 40, Issue 3, 2013, Pages 205-207

  Flaherty, Anne Marie C ^a  

^a HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CHEMICALLY INDUCED DISORDER; HISTORY; HUMAN; NAUSEA; NEOPLASM; NURSING; ONCOLOGY NURSING; REVIEW; VOMITING;

ANTINEOPLASTIC AGENTS; HISTORY, 20TH CENTURY; HUMANS; NAUSEA; NEOPLASMS; ONCOLOGY NURSING; VOMITING;

EID: 84876926477     PISSN: 0190535X     EISSN: 15380688     Source Type: Journal    
DOI: 10.1188/13.ONF.205-207     Document Type: Review

References (17)

1. Aapro, M.S. (1982). Effects and side-effects of cisplatin. Lancet, 1, 682-684.
2. Cotter, J. (2009). Efficacy of crude marijuana and synthetic delta-9-tetrahydrocannabinol as treatment for chemotherapy-induced nausea and vomiting: A systematic literature review. Oncology Nursing Forum, 36, 345-352.
3. Eagan, A.P., Taggart, J.R., & Bender C.M. (1992). Management of chemotherapy-related nausea and vomiting using a serotonin antagonist. Oncology Nursing Forum, 19, 791-795.
4. Engstrom, C., Hernanadez, I., Haywood, J., &Lilenbaum, R. (1999). The efficacy and cost effectiveness of new antiemetic guidelines. Oncology Nursing Forum, 26, 1453-1456.
5. Gralla, R.J., Itri, L.M., Pisko, S.E., Squillante, A.E., Kelsen, D.P., Braun, D.W., Jr., . . . Young, C.W. (1981). Antiemetic efficacy of high-dose metoclopramide: Randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting. New England Journal of Medicine, 305, 905-909. doi:10.1056/NEJM198110153051601
6. Gralla, R.J., Osoba, D., Kris, M.G., Kirkbride, P., Hesketh, P.J., Chinnery, L.W., . . . Pfister, D.G. (1999). Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines - American Society of Clinical Oncology. Journal of Clinical Oncology, 17, 2971-2994.
7. Grunberg, S.M., Deuson, R.R., Mavros, P., Geling, O., Hansen, M., Cruciani, G., . . . Daugaard G. (2004). Incidence of chemotherapy-induced nausea and emesis after modern antiemetics. Cancer, 100, 2261-2268.
8. Marek, C. (2003). Antiemetic therapy in patients receiving cancer chemotherapy. Oncology Nursing Forum, 30, 259-271.
9. Maxwell, M.B. (1982). Special feature: In quest of an effective antiemetic in cancer chemotherapy. Research with antiemetics for cancer chemotherapy: Problems and possibilities. Oncology Nursing Forum, 9(3), 11-16.
10. Mayer Scogna, D. (1977, July). Variables affecting nausea and vomiting. Oncology Nursing Society Newsletter, 5-7.
11. National Comprehensive Cancer Network.(2012). NCCN Clinical Practice Guidelines: Antiemesis [v.1.2012]. Retrieved from http://www.nccn.org/ professionals/physician-gls/pdf/antiemesis.pdf
12. Price, H., Williams, C.J., & Sergiou, K. (1992). A randomized trial of acupressure for chemotherapy induced emesis [Abstract 1394]. Paper presented at the Proceedings of the American Society of Clinical Oncology in San Diego, CA.
13. Rhodes, V.A., Watson, P.M., Johnson, M.H., Madsen, R.W., & Beck, N.C. (1987). Patterns of nausea, vomiting, and distress in patients receiving antineoplastic drug protocols. Oncology Nursing Forum, 14(4), 35-44.
14. Roila, F., Herrstedt, J., Aapro, M., Gralla, R.J., Einhorn, L.H., Ballatori, E., . . . Warr, D. (2010). Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting. Annals of Oncology, 21(Suppl. 5), v232-v243.
15. Suh, E.E. (2012). The effects of P6 acupressure and nurse-provided counseling on chemotherapy-induced nausea and vomiting in patients with breast cancer [Online exclusive]. Oncology Nursing Forum, 39, E1-E9.
16. U.S. Food and Drug Administration. (2011). FDA drug safety communication: Abnormal heart rhythms may be associated with use of Zofran® (ondansetron).Retrieved from http://www.fda.gov/Drugs/DrugSafety/ucm271913.htm
17. Wickham, R. (1989). Managing chemotherapy-related nausea and vomiting: The state of the art. Oncology Nursing Forum, 16, 563-574.